Startups
Vaxxel is an Innovative viral live-attenuated platform for intranasal vaccine candidates preventing against pneumovirus infections
Summary
10
Industry
Total funding Amount
$1.3M
Fundraising History
-
Mar 01 '22 Seed$1.3M